The world today is split between those who have cannabis for the high it produces and those who are more interested in its medicinal benefits and not much into euphoria. For the latter, it is good news as a Florida-based cannabis company has found a way to produce a cannabis plant variation that is tetrahydrocannabinol-free (THC-free). Considering the strict hemp laws that are already in place which makes the life of CBD product producers difficult as they are only allowed to manufacture CBD products from plants with less than 0.3% THC content, this is good news for them as well Hapé.
Oglesby Plants International
Oglesby Plants International, a wholesale plant nursery in Calhoun County, Florida, is responsible for producing the world’s first THC-free cannabis plant. Florida A&M University approved the strain under an Industrial Hemp Pilot Project. Currently, the project is administered by the Florida Department of Agriculture and Consumer Services. Bazelet Oglesby, a subsidiary of Bazelet Health Systems and Oglesby Plants International, focuses on plant breeding, plant tissue culture, the propagation of young hemp plants, and plant-based product development. A patent has been issued under its name.
Panakeia and The Future of Cannabis
With no Delta-8 or Delta-9 THC and with a significant concentration of cannabigerol (CBG), Panakeia will have a remarkable commercial value. Bazelet Research has studied this molecule (CBG) for years. CBG is the decarboxylated form of cannabigerolic acid (CBGA), the parent molecule from which other cannabinoids are synthesized.
The Panakeia plants are expected to be ready for cultivation by 2021 which indicates that new CBD products from these plants would surely flood the US markets with an even better value proposition. The CBG compounds can be incorporated in a wide range of products including cosmetics, foods, and nutraceuticals. The continued legalization across the US and many other countries around the globe have given cultivators the freedom to develop new strains such as this that have distinctive properties. These innovations show us that there is much more to cannabis than just CBD and THC, and we should keep our eyes open to such changes.
Before CBD came into the picture, producers were focused on cultivating cannabis that was high in THC concentrations. However, a new population became cannabis consumers since CBD products flushed the markets. This section of consumers was not interested in the high that cannabis is most associated with rather was keener on the medicinal alternatives that CBD products claim to provide. Because of the mainstream CBD promotions and the increase in demand cultivators are constantly looking for new cross-breed products with even less THC. Much like craft beer, craft cannabis is something that will be more popular in the near future.
CBG in Details
Often called the mother of all cannabinoids, CBG’s acidic form CBGA is the compound from which all other cannabinoids are derived. CBG is present in small amounts, often below 1%, in most cannabis plants with either CBD or THC dominating depending on the type of plantations. There are however a few strains with higher CBG content such as Super Glue CBG, White CBG, and Jack Frost CBG. Younger cannabis plants are rich in CBG. In the later stages, CBD and THC are derived from CBGA, the acidic form of CBG. CBG has more things in common with CBD than THC. Unlike THC, CBG doesn’t produce euphoria or the high much like CBD. Due to the difficulty in extracting CBG from the plant, producers are trying cross-breeding and genetic manipulation to make the plant be inherently rich in the compound. One such outcome is Panakeia.
Conclusion
With new research studies showcasing the potential health benefits of medical cannabis and with the rise in new tech-savvy companies driving this industry forward, people are more aware today of the cannabis products and are more interested in trying them out than ever before. And this is only going to rise with the continued legalization of the medical use of marijuana. Panakeia is not just an innovation; it is the outcome of a trend to learn more about cannabis and the outcome of research that started over a decade ago.